- Medtronic, Inc. (NYSE:MDT) was upgraded by analysts at Credit Suisse from a "neutral" rating to an "outperform" rating. They now have a $70.00 price target on the stock, up previously from $66.00. 16.6% upside from the previous close of $60.03. Tweet This.
- Medtronic, Inc. (NYSE:MDT) was upgraded by analysts at RBC Capital from a "sector perform" rating to an "outperform" rating. They now have a $73.00 price target on the stock, up previously from $61.00. 21.6% upside from the previous close of $60.03. Tweet This.
- Medtronic, Inc. (NYSE:MDT) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $42.00 price target on the stock, down previously from $66.00. 30.0% downside from the previous close of $60.03. Tweet This.
- Medtronic, Inc. (NYSE:MDT) was upgraded by analysts at BTIG Research from a "neutral" rating to a "buy" rating. They now have a $73.00 price target on the stock. 21.6% upside from the previous close of $60.03.Tweet This.
Medtronic Upgraded By Four Firms Today :-) AMAZING!!!!!!!!
Medtronic Upgraded by Four Firms today :-) AMAZING!!!!!!!!
Disclaimer:
None.
Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here.
Comments
Log in or sign up to join the conversation.